APOGEE THERAPEUTICS INC. - COMMON STOCK
56.52
12-November-24 14:59:15
15 minutes delayed
Stocks
-3.94
-6.52%
Today's range
56.21 - 61.05
ISIN
N/A
Source
NASDAQ
-
Apogee Therapeutics Provides Pipeline Progress and Reports Third Quarter 2024 Financial Results
12 Nov 2024 07:00:01 By Nasdaq GlobeNewswire
-
Apogee Therapeutics to Participate in Upcoming November Investor Conferences
04 Nov 2024 07:30:00 By Nasdaq GlobeNewswire
-
Apogee Therapeutics Announces Poster Presentation at the ACAAI 2024 Annual Scientific Meeting
16 Oct 2024 07:00:00 By Nasdaq GlobeNewswire
-
Apogee Therapeutics to Participate at the Stifel 2024 Immunology and Inflammation Summit
12 Sep 2024 07:00:00 By Nasdaq GlobeNewswire
-
Apogee Therapeutics Appoints Jeff S. Hartness as Chief Commercial Officer
09 Sep 2024 07:00:00 By Nasdaq GlobeNewswire
-
Apogee Therapeutics Provides Pipeline Progress and Reports Second Quarter 2024 Financial Results
12 Aug 2024 06:30:00 By Nasdaq GlobeNewswire
-
Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
28 May 2024 07:30:00 By Nasdaq GlobeNewswire
-
Apogee Therapeutics to Participate in Upcoming June Investor Conferences
23 May 2024 07:30:00 By Nasdaq GlobeNewswire
-
Apogee Therapeutics Highlights Pipeline Progress and Reports First Quarter 2024 Financial Results
13 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
Apogee Therapeutics to Participate at the 2024 Bank of America Healthcare Conference
06 May 2024 08:00:00 By Nasdaq GlobeNewswire
-
Apogee Therapeutics, Inc. Announces Pricing of Upsized $420 Million Underwritten Public Offering
07 Mar 2024 18:49:51 By Nasdaq GlobeNewswire
-
Apogee Therapeutics, Inc. Announces Proposed Underwritten Public Offering
05 Mar 2024 16:23:09 By Nasdaq GlobeNewswire
-
05 Mar 2024 06:10:00 By Nasdaq GlobeNewswire
-
05 Mar 2024 06:00:00 By Nasdaq GlobeNewswire
-
04 Mar 2024 16:01:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >